UBS AM
MYOV

UBS AM’s Myovant Sciences Ltd. MYOV Stock Holding History

UBS AM’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-31,713
Closed -$855K – 2744
2022
Q4 		$855K Sell
31,713
-730
-2% -$19.2K ﹤0.01% 1924
2022
Q3 		$583K Buy
32,443
+1
+0% +$16 ﹤0.01% 2280
2022
Q2 		$403K Hold
32,442
– – ﹤0.01% 2381
2022
Q1 		$432K Hold
32,442
– – ﹤0.01% 2506
2021
Q4 		$505K Hold
32,442
– – ﹤0.01% 2558
2021
Q3 		$728K Hold
32,442
– – ﹤0.01% 2325
2021
Q2 		$739K Buy
32,442
+2,812
+9% +$59.2K ﹤0.01% 2365
2021
Q1 		$610K Sell
29,630
-10,163
-26% -$231K ﹤0.01% 2319
2020
Q4 		$1.1M Buy
39,793
+4,447
+13% +$86.6K ﹤0.01% 1942
2020
Q3 		$497K Sell
35,346
-13,603
-28% -$253K ﹤0.01% 2147
2020
Q2 		$1.01M Buy
48,949
+23,106
+89% +$314K ﹤0.01% 1802
2020
Q1 		$195K Sell
25,843
-3,847
-13% -$43.1K ﹤0.01% 2285
2019
Q4 		$461K Buy
+29,690
New +$299K ﹤0.01% 2269

Other funds holding MYOV

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

UBS AM's MYOV Position: Q1 2023 in Review

UBS AM sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 31,713 shares — an estimated $855K sold.

UBS AM first reported a position in MYOV in Q4 2019 and held it in 13 quarters. The position peaked at $1.1M in Q4 2020. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • UBS AM reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • UBS AM sold 31,713 Myovant Sciences Ltd. shares in Q1 2023, an estimated $855K.
  • UBS AM first reported a position in Myovant Sciences Ltd. in Q4 2019 and held it in 13 quarters.
  • UBS AM's Myovant Sciences Ltd. position peaked at $1.1M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on UBS AM's 13F filing for Q1 2023, filed 15 May 2023.